and Chapman et al. (1961) perfused human skin in the region in which axon reflex vasodilatation had been induced by histamine or injury or in which vasodilatation had been produced by antidromic stimulation of cut posterior roots. The perfusate from such areas contained a substance which in many respects resembled bradykinin, but because it was not identical with bradykinin Chapman et al. (1961) suggested that it be called 'neurokinin'. If 'neurokinin' is a plasma kinin-like polypeptide it might be formed by release of a protease from the nerve terminals. However, Keele & Armstrong (1964) feel that 'neurokinin' is probably a mixture of bradykinin with histamine and perhaps other substances as well.
To return to the anti-inflammatory action of aspirin. Truelove & Duthie (1959) showed that aspirin, given orally in a dose of 650 mg, inhibited the early phase oferythema, cedema and surrounding flare evoked by application of 5% thurfyl nicotinate cream to human skin, though the later phase, of erythema alone, after 2-21 hours was not affected. Adams (1963) confirmed this finding and also made the astonishing observation that a single 650 mg dose of aspirin suppressed the early response to thurfyl nicotinate for several days. In animal experiments Mr D M Brown, Head of the Medicinal Research Division of Beecham Research Laboratories, has told me that aspirin, sodium salicylate and phenylbutazone suppress the inflammatory responses induced by thurfyl nicotinate in guinea-pig skin, or by xylol in the mouse's ear. Adrenal corticosteroids did not have this action. If we accept that these types of inflammation are neurally mediated (via axon reflexes), then it may be suggested that aspirin acts by blocking neurogenic inflammation, perhaps by preventing release of the antidromic neurohumoral mediator or by antagonizing its action. This view is very speculative but it could easily be put to experimental test by repeating the studies of Jancso et al. on antidromic stimulation of the saphenous nerve before and after administration of anti-inflammatory drugs. If the known drugs are not effective it would be useful to find new drugs which would suppress neurogenic inflammation so that the importance of this component of inflammation could be assessed by some means other than surgical denervation.
To summarize my own views of the evidence:
(1) The antipyretic action of aspirin and related drugs is a central one on the temperatureregulating region of the hypothalamus.
(2) The analgesic action is predominantly peripheral, probably at receptors in nerve terminals.
(3) The anti-inflammatory effect is also peripheral but may be mediated by axon reflex inhibition.
Dr F Dudley Hart (Westminster Hospital, London)

Selection of Analgesics in the Treatment of the Rheumatic Disorders [Summary]
What is pain in the rheumatic disorders? It is a different cocktail of discomforts, a different devil's brew, in the various conditions. An attack of gout, for instance, is an acute inflammatory agony. There are few psychic overtones here: fury, perhaps, at being kept from work or play, but in general this is a severe pain due to acute inflammation, remarkable only in its intensity. Reiter's (Brodie's) disease can also come into the agony class, and with it overtones of systemic illness and sometimes, in my experience, shame or a sense of guilt if contracted as a venereal disease. Osteoarthrosis is a varying painful disorder, depending on the area affected, hip, knee, neck or head. In ankylosing spondylitis stiffness and the aggravation of painful stiffness by immobility and prolonged rest is the main characteristic. Painful stiffness on first waking in the morning is often the worst time in the 24 hours for these patients, as it may be in some cases of rheumatoid arthritis, prolapsed intervertebral lumbar disc and giant cell arteritis.
The most complex of all is the pain of an acute active progressive polyarthritis such as rheumatoid arthritis where, locally in the affected joints, there is a blend of weakness, pain, stiffness, swelling and dysfunction, and referred pains causing tissues to ache between the joints, as in the muscles of thigh and forearm; there is also an overall so-called 'toxic' or 'ill' feeling, with aching, fever, sweating and tachycardia, and in such a chronic painful disorder there are often superadded overtones of spiritual distress: depression, anxiety concerning the future, tension, even despair. All this is covered by the inadequate, feeble portmanteau word 'pain'.
The analgesics at our command for use in these conditions fall into three groups. In Group I are those without anti-inflammatory action, such as paracetamol, codeine, dihydrocodeine and dextropropoxyphene. In Group 2 are the antiinflammatory, analgesic, antipyretic drugs, such as aspirin in all its various forms, the pyrazoles, phenylbutazone and oxyphenbutazone, the anthranilic compounds, flufenamic and mefenamic acids, and indomethacin. Group 3 contains the potentially addictive drugs which come under the Dangerous Drugs Act such as dipipanone and pethidine; pentazocine, a relative newcomer, seems to be unusual in apparently not having addictive properties on present evidence. But in addition to these three groups there are numbers of other drugs which, though not analgesics, help to ease painthe corticosteroids by reducing inflammatory changes, and the psychotropics by affecting mood and relieving stress, tension, depression and anxiety.
Which drug, then, for which condition? This is an impossible question to answer. In general my preference in acute gout is indomethacin, phenylbutazone, oxyphenbutazone and colchicine, in that order. Corticosteroids I reserve for the occasional resistant cases not responding to the first-named drugs. In ankylosing spondylitis, for patients needing more than salicylates, I favour phenylbutazone, oxyphenbutazone or indomethacin: the last I try first because of the remote, but very real, risk of causing a blood dyscrasia with the pyrazoles: I have not been greatly impressed with flufenamic or mefenamic acids in this condition. The aim here is to maintain as full mobility as possible: exercise and exercises are essential for the stiffening spondylitic, and analgesics help greatly in this respect.
In osteoarthrosis, as in all painful arthropathies involving weight-bearing joints, it does not matter what preparation is used; the weight-bearing joints such as hip or knee must be spared not only too much standing and walking, but also prolonged immobility in flexion, which also aggravates pain. Here the first choice is salicylates; only if these are ineffective or poorly tolerated is one of the other preparations used. Paracetamol and dextropropoxyphene, though relatively weak analgesics, share the great virtue of being well tolerated by the gastrointestinal tract. Indomethacin and the pyrazoles, though more effective, may cause dyspepsia, the anthranilics diarrheea. Cranial arteritis and polymyalgia rheumatica, often one and the same disease, respond far better to an effective anti-inflammatory agent such as prednisolone than to any analgesic.
The most subtle of all therapies however, is called for in the management of cases of rheumatoid arthritis. Here it is seldom that one can get even partial control of pain with one drug alone. Many pain-wracked, sad subjects need anything from 2 to 6 drugs before life becomes reasonably tolerable, e.g. gold salts as a long-term antiinflammatory agent, aspirin for painful periods in the day, 5 mg of prednisolone by mouth or indomethacin by suppository or by mouth at night to ease painful morning stiffness, an antidepressant such as amitriptyline or imipramine if depression is a prominent feature of the case, diazepam or a similar drug if an anxiety state is present, and so on. Drugs such as dipipanone alone or with cyclizine hydrochloride may be used occasionally, but as they come under the Dangerous Drugs Act they are best avoided except when pain is severe. We have found in the past that they can often be avoided by the administration of mist. aspirin (06-1 g) with tinct. opii (0 6-1 ml) or mist. paracetamol (1-1 5 g) with tinct. opii (0 6-1 ml) given only occasionally. The latter is well tolerated, but because of the gastric irritation sometimes caused by the former we have replaced it with tablets of aspirin (06 g) with papaveretum (10 mg), taken as an 'agony dose' only when really required. At night an intramuscular injection of dihydrocodeine (50-100 mg) or; pentazocine (30-60 mg) may be given if pain is severe and prevents sleep and is not controlled by simpler measures. Heavy sedation at night may make rheumatoid arthritis worse by increasing painful morning stiffness, and an effective analgesic with lighter sedation is preferable in most cases. In the day occupational or diversional therapy in any form that interests and occupies the patient helps to reduce the amount of analgesic required, but at night pain may make its presence felt more when there is little escape from it.
Control of pain in the rheumatic disorders is as much an art as a science: much of the art lies in listening to the patient's story and prescribing accordingly.
